DrugPatentWatch Database Preview
Details for Patent: 9,375,410
» See Plans and Pricing
Which drugs does patent 9,375,410 protect, and when does it expire?
Patent 9,375,410 protects AMRIX and is included in one NDA.
This patent has one patent family member in one country.
Summary for Patent: 9,375,410
| Title: | Modified release dosage forms of skeletal muscle relaxants |
| Abstract: | A unit dosage form, such as a capsule or the like, for delivering a skeletal muscle relaxant, such as cyclobenzaprine hydrochloride, into the body in an extended or sustained release fashion comprising one or more populations of drug-containing particles (beads, pellets, granules, etc.) is disclosed. At least one bead population exhibits a pre-designed sustained release profile. Such a drug delivery system is designed for once-daily oral administration to maintain an adequate plasma concentration-time profile, thereby providing relief of muscle spasm associated with painful musculoskeletal conditions over a 24 hour period. |
| Inventor(s): | Venkatesh; Gopi M. (Vandalia, OH), Clevenger; James M. (Vandalia, OH) |
| Assignee: | ADARE PHARMACEUTICALS, INC. (Lawrenceville, NJ) |
| Application Number: | 14/496,890 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,375,410 |
|
Patent Claim Types: see list of patent claims | Use; Formulation; Dosage form; Composition; |
Drugs Protected by US Patent 9,375,410
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva Pharms Intl | AMRIX | cyclobenzaprine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 021777-001 | Feb 1, 2007 | AB | RX | Yes | No | Start Trial | Start Trial | RELIEF OF MUSCLE SPASM | Start Trial | |||
| Teva Pharms Intl | AMRIX | cyclobenzaprine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 021777-002 | Feb 1, 2007 | AB | RX | Yes | Yes | Start Trial | Start Trial | RELIEF OF MUSCLE SPASM | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,375,410
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| World Intellectual Property Organization (WIPO) | 2005048996 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
